|
44 |
Announcement of merger termination report
|
2019.10.02 |
|
43 |
Notice of objection to creditor
|
2019.08.16 |
|
42 |
Small merger announcement
|
2019.07.17 |
|
41 |
Guidance on the protection and measures for sovereign right …
|
2019.07.03 |
|
40 |
Genematrix acquired product license for sexual infection mul…
|
2017.07.19 |
|
39 |
Genematrix, Korea Centers for Disease Control and Prevention…
|
2017.07.03 |
|
38 |
HBI listed AIDS/syphilis test as recommended test in Philipp…
|
2017.05.25 |
|
37 |
GeneMatrix acquired a patent for the method of sequencing th…
|
2017.05.17 |
|
36 |
GeneMatrix enters the high-risk sexual infection diagnosis m…
|
2017.03.08 |
|
35 |
New cervical cancer diagnosis (OmniPlex-HPV) obtained approv…
|
2017.02.16 |
|
34 |
GeneMatrix commercializes molecular diagnostic products with…
|
2016.11.01 |
|
33 |
Gene Matrix, Zika virus vaccine development government servi…
|
2016.09.29 |
|
32 |
Gene Matrix, agreement on development of new and variant res…
|
2016.09.05 |
|
31 |
Gene Matrix acquires a European patent for “gene amplificati…
|
2016.07.11 |
|
30 |
Gene Matrix, commercialized products for early diagnosis of …
|
2016.05.11 |
ARE